Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 29-mRNA host response test to identify bacterial and viral infections and to predict 30-day mortality in emergency department patients with suspected infections: A prospective observational cohort study.
Tong-Minh K, van Leeuwen L, Ramakers C, Chen UI, Liesenfeld O, Gommers D, van Gorp E, Endeman H, van der Does Y. Tong-Minh K, et al. Among authors: van gorp e. Diagn Microbiol Infect Dis. 2024 Nov 26;111(3):116599. doi: 10.1016/j.diagmicrobio.2024.116599. Online ahead of print. Diagn Microbiol Infect Dis. 2024. PMID: 39657556 Free article.
Performance of the FebriDx Rapid Point-of-Care Test for Differentiating Bacterial and Viral Respiratory Tract Infections in Patients with a Suspected Respiratory Tract Infection in the Emergency Department.
Tong-Minh K, Daenen K, Endeman H, Ramakers C, Gommers D, van Gorp E, van der Does Y. Tong-Minh K, et al. Among authors: van der does y, van gorp e. J Clin Med. 2023 Dec 27;13(1):163. doi: 10.3390/jcm13010163. J Clin Med. 2023. PMID: 38202172 Free PMC article.
Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care.
Goeijenbier M, van der Bie S, Souverein D, Bolluyt D, Nagel M, Stoof SP, Vermin B, Weenink J, van Gorp ECM, Euser S, Kalpoe J, van Houten MA, Endeman H, Gommers D, Haas LEM, van Lelyveld SFL. Goeijenbier M, et al. Among authors: van gorp ecm. J Clin Med. 2024 Jun 12;13(12):3443. doi: 10.3390/jcm13123443. J Clin Med. 2024. PMID: 38929972 Free PMC article.
The role of antibody-dependent enhancement in dengue vaccination.
Aynekulu Mersha DG, van der Sterren I, van Leeuwen LPM, Langerak T, Hakim MS, Martina B, van Lelyveld SFL, van Gorp ECM. Aynekulu Mersha DG, et al. Among authors: van gorp ecm. Trop Dis Travel Med Vaccines. 2024 Nov 1;10(1):22. doi: 10.1186/s40794-024-00231-2. Trop Dis Travel Med Vaccines. 2024. PMID: 39482727 Free PMC article.
Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression.
Daenen K, van Hooijdonk S, Tong-Minh K, Dik WA, van Hagen PM, Huijben JA, Gommers D, van Gorp ECM, Endeman H, Dalm VASH. Daenen K, et al. Among authors: van gorp ecm. Front Immunol. 2024 Dec 3;15:1436637. doi: 10.3389/fimmu.2024.1436637. eCollection 2024. Front Immunol. 2024. PMID: 39691720 Free PMC article.
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024. Front Immunol. 2024. PMID: 38698851 Free PMC article.
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
van Leeuwen LP, Shamier MC, Verstrepen BE, Götz HM, Schmitz KS, Akhiyate N, Wijnans K, Bogers S, van Royen ME, van Gorp EC, Koopmans MP, de Vries RD, GeurtsvanKessel CH, Zaeck LM. van Leeuwen LP, et al. Among authors: van gorp ec. Euro Surveill. 2024 Sep;29(38):2400575. doi: 10.2807/1560-7917.ES.2024.29.38.2400575. Euro Surveill. 2024. PMID: 39301741 Free PMC article.
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial.
Raadsen MP, Dahlke C, Fathi A, Hardtke S, Klüver M, Krähling V, Gerresheim GK, Mayer L, Mykytyn AZ, Weskamm LM, Zoran T, van Gorp ECM, Sutter G, Becker S, Haagmans BL, Addo MM; MVA-MERS-S_DF-1 Study group. Raadsen MP, et al. Among authors: van gorp ecm. Lancet Infect Dis. 2024 Oct 7:S1473-3099(24)00423-7. doi: 10.1016/S1473-3099(24)00423-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39389076
Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortium.
Avelino-Silva VI, Mayaud P, Tami A, Miranda MC, Rosenberger KD, Alexander N, Nacul L, Segurado A, Pohl M, Bethencourt S, Villar LA, Viana IFT, Rabello R, Soria C, Salgado SP, Gotuzzo E, Guzmán MG, Martínez PA, López-Gatell H, Hegewisch-Taylor J, Borja-Aburto VH, Gonzalez C, Netto EM, Saba Villarroel PM, Hoen B, Brasil P, Marques ETA, Rockx B, Koopmans M, de Lamballerie X, Jaenisch T; ZIKAlliance Clinical Study Group. Avelino-Silva VI, et al. BMC Infect Dis. 2019 Dec 26;19(1):1081. doi: 10.1186/s12879-019-4685-9. BMC Infect Dis. 2019. PMID: 31878895 Free PMC article.
293 results